Latest Breaking News On - Psoriasis area - Page 1 : comparemela.com
SAN FRANCISCO and SUZHOU, China, May 28, 2024 /PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced that picankibart (R & D code: IBI112), a recombinant anti-interleukin 23p19 subunit (IL-23p19) antibody injection, has met all.
SuzhouJiangsuChinaShanghaiYulin-shiShaanxiChineseEli-lillyAdimab-incyteInnovent-biologicsNational-medical-product-administrationPrnewswire-innovent-biologics-inc